Such mass spectrometry-based proteomics-driven discoveries have expanded the CTX interactome beyond MMP-2, ClC-3, and annexin A2, highlighting neuropilin-1 (NRP1) as another critical binding partner for tumor selectivity [167,168]. Here, CLCN3 is linked to neoplasm.